[February 14, 2008]

Roth 2008 OC Conference Presenter Profiles

Company:             A.D.A.M., Inc.
Ticker Symbol & Exchange:     ADAM
Investor Relations Contact:    Victor Thompson
Investor Relations Contact Phone: 770-321-4326
Web:               [email protected]
Date of Presentation:       2/19/08
A.D.A.M. (Nasdaq: ADAM - News) is a leading provider of high-quality
health information and benefits management solutions to healthcare
organizations, employers, consumers, and educational institutions.
With an industry-leading employee and HR benefits management platform
and one of the largest consumer health information libraries in the
world, A.D.A.M. empowers consumers to get smart about their health
and wellness, while reducing the costs of healthcare and benefits
administration. A.D.A.M.'s products address an over $1 billion and
growing consumer driven healthcare market. For more information,
visit www.adam.com or call 1-800-408-ADAM.
Company:             Acacia Research Corporation
Ticker Symbol & Exchange:     ACTG Nasdaq
Investor Relations Contact:    Rob Stewart
Investor Relations Contact Phone: 949-480-8300
Web:               www.acaciaresearch.com
Date of Presentation:       2/21/08
Acacia Research's subsidiaries are in the business of acquiring,
developing, licensing and enforcing patents. We help patent holders
protect their patented inventions from unauthorized use and generate
revenue from licensing and, if necessary, enforcing their patents.
Our clients are primarily individual inventors and small companies
with limited resources to deal with unauthorized users but include
some large companies wanting to generate revenues from their patented
technologies.
Company:             Access Integrated Technologies, Inc.
Ticker Symbol & Exchange:     NASDAQ: AIXD
Investor Relations Contact:    Suzanne Moore
Investor Relations Contact Phone: 973-290-0056
Web:               www.accessitx.com
Date of Presentation:       2/19/08
Access Integrated Technologies, Inc. (AccessIT) is the global leader
in providing integrated solutions for digital cinema. The Company's
ground-breaking digital cinema networked services along with its
Library Management Server(TM) and Theatre Command Center(TM) have
enabled theatres across the United States to play almost five million
digital showings of Hollywood features to date. AccessIT's
comprehensive vendor neutral solutions provide pre-show
entertainment, feature movies and live and pre-recorded alternative
content via satellite to expand box office sales and develop new ways
to attract incremental revenues.
Company:             Amerigon Incorporated
Ticker Symbol & Exchange:     NASDAQ:ARGN
Investor Relations Contact:    Jill Bertotti
Investor Relations Contact Phone: 949-474-4300
Web:               www.amerigon.com
Date of Presentation:       Feb. 20
Amerigon develops products based on its advanced, proprietary,
efficient thermoelectric technologies for a wide range of global
markets and heating and cooling applications. Amerigon's initial
product, the Climate Control Seat(TM) (CCS(TM)) system, is a heated
and cooled seat system for automotive vehicles that allows individual
control for year-round comfort. It is currently available on multiple
vehicles in the U.S., Europe and Asia with five automotive
manufacturers - Ford, General Motors, Toyota, Nissan and Hyundai.
Working with partners that include Herman Miller, Visteon, the U.S.
Department of Energy, Carrier Corporation as well as others, Amerigon
expects in the near future to broaden the use of its thermoelectric
technology beyond its initial automotive seat system to larger
opportunity markets that require heating and cooling.
Company:             Ascend/ePAK
Ticker Symbol & Exchange:     ASAQ
Investor Relations Contact:    Crocker Coulson
Investor Relations Contact Phone: 646-213-1915
Web:               www.ascendgrowth.com
Date of Presentation:       2/20/08
Ascend is a special purpose acquisition company which has identified
ePAK as its target. ePAK is a full service designer, manufacturer and
supplier of precision engineered products and solutions for the
automated transport and handling of semiconductor and electronic
devices. Demand for ePAK's products is driven by unit volume growth
of semiconductors, which has historically demonstrated consistent
growth and low volatility. ePAK has a track record of accelerating
revenues and earnings and recently entered the high-margin wafer
handling business. The merger with Ascend will provide ePAK with $40
million in additional capital to pursue growth opportunities. More
information on ePAK is available in Ascend's filings with the SEC.
Company:             AspenBio Pharma Inc.
Ticker Symbol & Exchange:     (Nasdaq:APPY)
Investor Relations Contact:    Liolios Group
Investor Relations Contact Phone: (949) 574-3860
Web:               www.aspenbiopharma.com
Date of Presentation:       Tuesday, February 19 at 3:00 PM PT
AspenBio Pharma is an emerging bio-pharmaceutical company dedicated to
the discovery, development, manufacture, and marketing of novel
proprietary products via two primary segments: 1) human medical
diagnostics and 2) animal pharma and diagnostics that enhance
reproductive efficiency. Both have high-dollar market potential
worldwide.
Founded in 2000 to produce purified proteins for diagnostic
applications, AspenBio has become a leading supplier of human
hormones for diagnostic use. The company has successfully leveraged
this science and technology to rapidly develop an enviable late-stage
pipeline of novel reproduction hormone analogs for wide-ranging
therapeutic use in animals.
Company:             Barrier Therapeutics, Inc.
Ticker Symbol & Exchange:     NASDAQ: BTRX
Investor Relations Contact:    Anne M. VanLent, EVP & CFO
Investor Relations Contact Phone: (609) 945-1202
Web:               www.barriertherapeutics.com
Date of Presentation:       1:30 p.m. Pacific Time on Wednesday
Barrier Therapeutics, Inc., headquartered in Princeton, New Jersey, is
a pharmaceutical company focused on the development and
commercialization of products in the field of dermatology. Barrier
currently markets three pharmaceutical products in the United States:
Xolegel(R) (ketoconazole, USP) Gel, 2%, for seborrheic dermatitis;
Vusion(R) (0.25% miconazole nitrate, 15% zinc oxide, 81.35% white
petrolatum) Ointment, for diaper dermatitis complicated by documented
candidiasis; and Solage(R) (mequinol 2.0%, tretinoin 0.01%) Topical
Solution, for solar lentigines. Barrier has other product candidates
in various stages of clinical development for the treatment
dermatological conditions, including onychomycosis, psoriasis, acne,
skin allergies, and superficial fungal infections.
Company:             Beijing Med-Pharm Corporation
Ticker Symbol & Exchange:     Nasdaq: BJGP
Investor Relations Contact:    Ashley Ammon MacFarlane
Investor Relations Contact Phone: 203-682-8200
Web:               www.beijingmedpharm.com
Date of Presentation:       2/20/08
Beijing Med-Pharm Corporation, through its subsidiaries, is a
pharmaceutical marketing and distribution company that is building a
proprietary portfolio of branded pharmaceutical and healthcare
products in China and is pursuing partnerships with other companies
seeking to enter the Chinese pharmaceutical market. It is the only
U.S. public company to offer industry partners a comprehensive suite
of market-entry services in China, including pre-market entry
analysis, clinical trial management, product registration, market
research, as well as pharmaceutical marketing and distribution. The
Company provides distribution services for a wide range of products,
including Western medicines and over-the-counter healthcare products.
Beijing Med-Pharm's proprietary portfolio primarily focuses on
women's health and pediatrics.
Company:             Bidz.com, Inc.
Ticker Symbol & Exchange:     NASDAQ: BIDZ
Investor Relations Contact:    Patricia Dolmatsky
Investor Relations Contact Phone: 310-954-1100
Web:               www.bidz.com
Date of Presentation:       2/20/08
Bidz.com, founded in 1998, is an online auctioneer of jewelry. Bidz
offers its products through a live auction format requiring only a $1
minimum opening bid. To learn more about Bidz.com visit its website
at www.bidz.com.
Company:             Bio-Imaging Technologies, Inc.
Ticker Symbol & Exchange:     NASDAQ: BITI
Investor Relations Contact:    Linda Decker
Investor Relations Contact Phone: 212 564 4700
Web:               www.bioimaging.com
Date of Presentation:       2/20/08
Bio-Imaging Technologies, Inc. is a healthcare contract service
organization providing services that support the product development
process of the pharmaceutical, biotechnology and medical device
industries. The Company has specialized in assisting its clients in
the design and management of the medical-imaging component of
clinical trials since 1990. Bio-Imaging serves its clients on a
global basis through its Core Labs in Newtown, PA, and Leiden, The
Netherlands, along with business offices in PA, MA, The Netherlands,
Germany and France. Through its CapMed Personal Health Management
Suite, Bio-Imaging provides its Personal HealthKey(TM) technology,
the Personal Health Record (PHR) software, and CapMed Patient Portal
allowing patients to better monitor and manage their health care
information.
Company:             BioDelivery Sciences International
Ticker Symbol & Exchange:     BDSI (NASDAQ)
Investor Relations Contact:    Mark Sirgo, President & CEO
Investor Relations Contact Phone: Mike Russel, FD Ashton 617-275-8746
Web:               www.biodeliverysciences.com
Date of Presentation:       2/20/08
BioDelivery Sciences is a specialty pharmaceutical company that is
exploiting licensed and proprietary patented drug delivery
technologies to develop and commercialize clinically-significant new
formulations of proven therapeutics. The company's development
strategy focuses on the utilization of the FDA's 505(b)(2) approval
process to obtain more timely and efficient approval of new
formulations of previously approved therapeutics. The company's
patented drug delivery technologies include the BEMA(TM)
(transmucosal, or applied to the inner cheek membrane) drug delivery
technology; and the Bioral(R) nanocochleate drug delivery technology,
which is designed to allow oral administration of drugs with
otherwise given by IV. The company's lead product is BEMA Fentanyl
for the treatment of breakthrough cancer pain (NDA Filed October
2007).
Company:             China Cablecom
Ticker Symbol & Exchange:     JGAC, OTCBB
Investor Relations Contact:    HC International, Inc.
Investor Relations Contact Phone: Ted Haberfield, 760-755-2716
Web:               www.chinacablecom.net
Date of Presentation:       2/20/08
China Cablecom, Ltd. is an emerging consolidator of cable network
operators and service providers with an established foothold in
Shandong Province's fast growing cable network market. Founded in
October 2006, China Cablecom focuses on building strategic
partnerships, and consolidating the operations of municipal and
county cable network operators in China's Shandong province.
Company:             China Direct, Inc.
Ticker Symbol & Exchange:     CDS, AMEX
Investor Relations Contact:    HC International, Inc.
Investor Relations Contact Phone: (914) 669-0222
Web:               www.cdii.net
Date of Presentation:       2/19/08
China Direct, Inc. is a U.S.-based company doing business in China
through two business divisions. The Company's management division
takes controlling stakes in Chinese companies, provides investment
capital and active management to enable these companies to thrive as
subsidiaries in their respective industries. The consulting division
assists companies in China and the U.S. in establishing and
maintaining a presence in the U.S. capital markets. As a direct link
to China, China Direct serves as a vehicle to allow investors to
directly participate in the rapid growth of the Chinese economy in a
diversified and balanced manner. The Company provided guidance of
$170 million in revenues for 2007 and $270 million for 2008 with
$10.5 million net and $20 million net respectively. Fully diluted EPS
guidance for 2007 is $0.60 and $0.95 in 2008.
Company:             China Housing & Land Development,
                 Inc.
Ticker Symbol & Exchange:     CHLN, OTCBB
Investor Relations Contact:    HC International, Inc.
Investor Relations Contact Phone: (914) 669-0222
Web:               www.chldinc.com
Date of Presentation:       2/20/08
Based in Xi'an, the capital city of the Shaanxi province in China,
China Housing & Land Development, Inc. is the largest private
developer of residential and commercial properties in the province.
China Housing has been an independent business since 1992 and became
a US publicly-traded company in 2006. China Housing has been named an
"AAA Enterprise in the Shaanxi Construction Industry" and has been
ranked as the #1 private housing and land development company as
recognized by the China Enterprise Confederation and China Directors'
Association. Additionally, the Company has attained "Level 1" status
which is the highest level awarded by the government and thus allows
the Company to develop small to large sized projects. For the first
nine months of 2007, total revenue was $26.3 million and net income
was $2.6 million.
Company:             China Natural Gas, Inc.
Ticker Symbol & Exchange:     OTC BB: CHNG
Investor Relations Contact:    Ashley Ammon MacFarlane
Investor Relations Contact Phone: 203-682-8200
Web:               http://www.naturalgaschina.com/
Date of Presentation:       2/21/08
China Natural Gas, Inc., ("CHNG"), is the first China-based natural
gas company publicly traded in the US. It currently owns and operates
a 120 kilometer long compressed natural gas pipeline in Xi'an, China,
a fast growing Chinese city supported by a population of
approximately eight million and is the "gateway" to the broad Western
regions of China. CHNG has three profitable business segments: end
user delivery of natural gas services to residential, commercial and
industrial customers; wholesale natural gas to retail natural gas
filling stations; and retail natural gas at company-owned natural gas
filling stations. The city of Xi'an has approximately 20,000 taxis,
3,000 buses and 2,000 special purpose vehicles that are powered by
compressed natural gas.
Company:             China Security & Surveillance Tech,
                 Inc.
Ticker Symbol & Exchange:     NYSE: CSR
Investor Relations Contact:    Kewa Luo
Investor Relations Contact Phone: 1-212-588-0885
Web:               www.csst.com
Date of Presentation:       2/20/08
Based in Shenzhen, China, China Security manufactures, distributes,
installs and maintains security and surveillance systems throughout
the PRC. China Security has manufacturing facilities located in China
and an R&D facility which maintains an exclusive collaboration
agreement with Beijing University. China Security has built a
diversified customer base through its extensive sales and service
network that includes numerous points of presence throughout the PRC.
Company:             China Solar & Clean Energy Solutions
                 Inc
Ticker Symbol & Exchange:     CSOL, OTCBB
Investor Relations Contact:    HC International, Inc.
Investor Relations Contact Phone: (914) 669-0222
Web:               www.cn-sce.com
Date of Presentation:       2/21/08
China Solar & Clean Energy Solutions, Inc. is a Clean Tech company
that provides renewable energy solutions to business and residential
customers in China. The Company is dedicated to reducing energy usage
and improving the environment in China while delivering substantial
economic benefits to its customers. The Company's Solar division
manufactures and installs water heating systems while its Energy
Recycling division provides systems to manufacturing facilities which
dramatically reduce external power consumption. For the first nine
months of 2007, sales increased 57% to $25 million with net income
increasing 35% to $1.4 million. EPS was $.20 versus $.13.
Company:             China TransInfo Technology Corp.
Ticker Symbol & Exchange:     CTFO.OB
Investor Relations Contact:    Crocker Coulson
Investor Relations Contact Phone: 646-213-1915
Web:               www.chinatransinfo.com
Date of Presentation:       2/19/08
China TransInfo Technology Corp. was established in October 2000 and
is headquartered in Beijing. Through its 95% owned subsidiary (the
other 5% is owned by Peking University), Beijing PKU ChinaFront High
Technology Co., Ltd., the Company uses a full range of self-developed
2-Dimension ("2D") and 3-Dimension ("3D") Geography Information
System (GIS) platforms to provide Total Solutions, Real Time Traffic
Information Platforms and composite software-hardware products. Most
of China TransInfo's offerings are geared towards the transportation
industry.
Company:             Cleveland BioLabs, Inc.
Ticker Symbol & Exchange:     Nasdaq: CBLI
Investor Relations Contact:    Rachel Levine
Investor Relations Contact Phone: 646-284-9439
Web:               www.cbiolabs.com
Date of Presentation:       2/19/08 at 5:00 pm
Originally a spin-out of the Cleveland Clinic and now partnered with
Roswell Park Cancer Institute, Cleveland BioLabs is a drug discovery
and development company leveraging its proprietary discoveries about
programmed cell death to develop two families of compounds.
Protectans are natural factors of microflora that protect healthy
tissues from acute stresses such as radiation, chemotherapy and
ischemia. Protectan CBLB502 is being developed through an expedited
pathway for acute radiation syndrome and for medical uses in reducing
cancer treatment side effects. Curaxins are anticancer agents that
act as mono-therapy drugs or in combination with other anticancer
agents. Curaxin CBLC102 is completing a Phase II trial in hormone
refractory prostate cancer.
Company:             ClickSoftware Technologies Ltd.
Ticker Symbol & Exchange:     CKSW
Investor Relations Contact:    Adam Rosen
Investor Relations Contact Phone: (646) 536-3865
Web:               www.clicksoftware.com
Date of Presentation:       2/20/08
ClickSoftware is the leading provider of mobile workforce management
and service optimization solutions that create business value for
service operations through higher levels of productivity, customer
satisfaction and cost effectiveness. From proactive customer demand
forecasting and capacity planning to real-time decision-making,
incorporating scheduling, mobility and location based services,
ClickSoftware helps service organizations get the most out of their
resources. With over 100 customers across a variety of industries and
geographies, and strong partnerships with leading platform and system
integration partners - ClickSoftware is uniquely positioned to
deliver superb business performance to any organization. The company
is headquartered in Burlington, MA and Israel, with offices in
Europe, and Asia Pacific.
Company:             Commtouch Software Ltd.
Ticker Symbol & Exchange:     CTCH
Investor Relations Contact:    Ron Ela, CFO
Investor Relations Contact Phone: 650-864-2291 / +972-9-8636813
Web:               www.commtouch.com
Date of Presentation:       Feb. 20, 1:00 pm
Commtouch Software Ltd. (NASDAQ: CTCH) is a global developer and
provider of email defense solutions, including Anti-Spam, Zero-
Hour(TM) Virus Outbreak Protection and GlobalView(TM) Reputation
Service, with over 17 years of messaging technology experience.
Patented Recurrent Pattern Detection(TM) technology analyzes billions
of email messages each week to identify new outbreaks and their
zombie-senders in real-time. Integrated by scores of OEM partners --
including Check Point Software, Panda Security, F-Secure, Fujitsu, LG
N-Sys, Sendmail and Watchguard -- Commtouch technology protects tens
of thousands of organizations in over 100 countries. Commtouch is
headquartered in Netanya, Israel, and has a subsidiary in Sunnyvale,
Calif.
Company:             Cortex Pharmaceuticals, Inc.
Ticker Symbol & Exchange:     COR
Investor Relations Contact:    Erika Moran, IRG, New York
Investor Relations Contact Phone: 212-825-3210
Web:               www.cortexpharm.com
Date of Presentation:       February 19, 2008 at 2:30 pm PST
Cortex Pharmaceuticals, Inc. is a neuroscience company focused on the
R&D of AMPAKINE(R), a pharmacology that represents a new approach to
treat psychiatric and neurological disorders. AMPAKINE compounds are
small molecules, which positively modulate the AMPA receptor in the
brain. Cortex's lead product, CX717, has demonstrated "Proof-of-
Concept" in adult ADHD patients in a Phase II study. Two Phase IIa
clinical studies for treatment of respiratory depression are
currently being initiated in Europe for completion in May, 2008. The
drugs improve memory in animal models for Alzheimer's disease and
prevent respiratory depression. Other AMPAKINES may provide a novel
treatment for Huntington's disease, Rett's and Fragile X syndromes.
Schering-Plough, a licensee, has two compounds in clinical trials.
Company:             Cutera, Inc.
Ticker Symbol & Exchange:     NASDAQ: CUTR
Investor Relations Contact:    John Mills
Investor Relations Contact Phone: 310-954-1100
Web:               www.cutera.com
Date of Presentation:       2/20/08 @ 10:30 a.m. PST
Brisbane, California-based Cutera is a leading provider of laser and
other light-based aesthetic systems for practitioners worldwide.
Since 1998, Cutera has been developing innovative, easy-to-use
products that enable physicians and other qualified practitioners to
offer safe and effective aesthetic treatments to their patients. For
more information, call 1-888-4CUTERA or visit www.cutera.com.
Company:             Diguang International Development
                 Co.
Ticker Symbol & Exchange:     DGNG (OTC BB)
Investor Relations Contact:    Sean Collins
Investor Relations Contact Phone: 310-497-9205
Web:               www.diguangintl.com
Date of Presentation:       Feb. 20, 2008
Diguang International, through its subsidiaries, specializes in the
research, development, production, sale and distribution of
backlights and backlight technologies. A backlight is the typical
light source of a liquid crystal display (LCD). The Company is
focused on providing LED and CCFL backlights for international
producers of televisions, monitors, cellular phones, digital cameras,
DVDs and other home appliances. Diguang currently develops an average
of approximately 50 new products per month. Diguang is a Nevada
corporation with its manufacturing subsidiary headquartered in
Shenzhen, PRC, and its sales and marketing subsidiary located in the
British Virgin Islands.
Company:             Disaboom
Ticker Symbol & Exchange:     NASDAQ-OTCBB (DSBO)
Investor Relations Contact:    Molly Plyler of BlueShirt Grp.
Investor Relations Contact Phone: (415) 217-5867
Web:               www.disaboom.com
Date of Presentation:       02-21-2008 at 8:30am
Disaboom.com is an interactive online community that combines
lifestyle and medical information, discussion boards, a career
center, and social networking opportunities for those with
disabilities as well as their family, friends, caregivers and health
providers. It was founded by Dr. J. Glen House, a physician
specializing in physical medicine and rehabilitation who is also a
quadriplegic. His firsthand knowledge of the challenges faced by
individuals with disabilities and those whose lives they touch has
driven the Disaboom.com mission: to create the first comprehensive,
evolving source of information, inspiration, insight, and personal
engagement for the disability community.
Company:             DRI Corporation
Ticker Symbol & Exchange:     TBUS
Investor Relations Contact:    Veronica B. Marks
Investor Relations Contact Phone: (214) 378-4776
Web:               www.digrec.com
Date of Presentation:       Feb. 21, 2008
DRI Corporation is a digital communications technology leader in the
domestic and international public transportation and transit security
markets. Our products include: TwinVision(R) and Mobitec(R)
electronic destination sign systems, Talking Bus(R) voice
announcement systems, Digital Recorders(R) Internet-based passenger
information and automatic vehicle location/monitoring systems, and
VacTell(TM) video actionable intelligence systems. Our products help
increase the mobility, flow, safety, and security of people who rely
upon transportation infrastructure around the globe. Our products
also aid transit vehicle operators in their quest to increase
ridership and reduce fuel consumption, as well as to identify and
mitigate security risks on transit vehicles.
Company:             Elbit Vision Systems
Ticker Symbol & Exchange:     EVSNF.OB
Investor Relations Contact:    CCGK - Kenny Green
Investor Relations Contact Phone: +972 545 551 470
Web:               www.evs-sm.com
Date of Presentation:       2/19/08
EVS is a fast growing microcap developer, and provider, of high-
throughput Automated Optical Inspection (AOI) and Automated
Ultrasonic (UT) Inspection and Imaging technologies.
EVS' systems are used by over 600 customers, many of which are leading
global companies. EVS is headquartered in Israel.
EVS' AOI systems are primarily targeted to textile, technical fabric,
and PCB board manufacturers for fast in-process, post production
quality assurance and yield enhancement.
EVS' UT systems are primarily targeted to the mission-critical
aerospace and rail industries. EVS' systems are used by many of the
top aerospace companies including: Boeing, Raytheon, Honeywell, Pratt
& Whitney and GE.
Company:             Ener1, Inc.
Ticker Symbol & Exchange:     ENEI OTCBB
Investor Relations Contact:    Jerry Herlihy
Investor Relations Contact Phone: 954 556-4020 x310
Web:               www.ener1.com
Date of Presentation:       2/21/08
Ener1, Inc. is leading the North American development and
commercialization of advanced, high-performance safe lithium ion (Li-
ion) batteries for hybrid electric vehicles (HEVs), Plug-in HEVs
(PHEVs) and Electric Vehicles (EVs). The company currently is
expanding production capacity at its Indianapolis manufacturing
facility to begin deliveries in late 2008 on a $70-million contract
for the Th!nk City electric vehicle and is also readying for
anticipated HEV volume production in 2010 and 2011. Our fuel cell
subsidiary is commercializing a low-power, high energy density,
portable fuel cell system and also developing a high temperature
stack system. EnerDel is a participant in the USABC HEV and PHEV
development programs.
Company:             EXFO Electro-Optical Engineering
                 Inc.
Ticker Symbol & Exchange:     EXFO, NASDAQ
Investor Relations Contact:    Vance Oliver
Investor Relations Contact Phone: (418) 683-0913, Ext. 3733
Web:               www.EXFO.com
Date of Presentation:       Feb. 19, 2008
EXFO is a Tier-1 test and measurement expert in the global
telecommunications industry, especially in the portable test market
segment. The Telecom Division, which represents about 85% of the
company's business, offers a full suite of test solutions to network
service providers, cable TV operators, telecom system vendors and
component manufacturers in approximately 70 countries. EXFO is the
global market leader for portable optical test solutions and a
leading supplier of protocol and access test solutions to enable
triple-play deployments and converged IP networking. The Life
Sciences and Industrial Division offers light-based solutions in
high-precision medical device and opto-electronics assembly sectors,
and advanced fluorescence microscopy and electrophysiology solutions
for the life sciences sector.
Company:             Flow International Corporation
Ticker Symbol & Exchange:     FLOW - NASDAQ
Investor Relations Contact:    Geoff Buscher
Investor Relations Contact Phone: 253-813-3286
Web:               www.flowcorp.com
Date of Presentation:       2/20/08, 10:30-11:00 am
Flow International Corporation is the world's leading developer and
manufacturer of ultrahigh-pressure waterjet cutting technology to
industries including automotive, aerospace, job shop, surface
preparation, and more.
Flow's UHP systems pressurize water from 40,000 to over 100,000 pounds
per square inch (psi). This high-pressure water is the core of Flow's
product line.
Company:             Fuel Tech
Ticker Symbol & Exchange:     NASDAQ: FTEK
Investor Relations Contact:    Tracy Krumme
Investor Relations Contact Phone: 203-425-9830
Web:               www.ftek.com
Date of Presentation:       Wednesday, Feb. 20th
Fuel Tech (NASDAQ: FTEK) is a fully integrated company utilizing a
suite of advanced technologies to provide boiler optimization,
efficiency improvement and air pollution reduction and control
solutions to utility and industrial customers worldwide. The
Company's NOx reduction and urea-to-ammonia conversion technologies
have established Fuel Tech as a leader in air pollution control
systems, with installations on over 450 units worldwide. The
Company's FUEL CHEM(R) process revolves around the unique application
of chemicals using TIFI(TM) Targeted In-Furnace Injection(TM)
technology to control slagging, fouling, corrosion, opacity, acid
plume and SO3 formation. This technology is being applied to over 90
combustion units.
Company:             Global Med Technologies, Inc.
Ticker Symbol & Exchange:     OTCBB: GLOB
Investor Relations Contact:    portfoliopr.inc
Investor Relations Contact Phone: Paul Holm, (212) 999-5585
Web:               www.globalmedtech.com
Date of Presentation:       Thursday, 2/21/2008 at 11:30 a.m.
Global Med Technologies(R), Inc. (OTCBB: GLOB) is an international e-
Health medical information technology company specializing in FDA-
cleared medical software for the healthcare industry. Currently,
Global Med designs, develops, markets and supports information
management software for blood banks, hospitals and centralized
transfusion centers. Revenues are derived from the licensing of
software, maintenance, professional services and other value-added
support services. Global Med's PeopleMed(R) subsidiary provides
custom software validation, consulting and compliance solutions to
hospitals and blood centers. Global Med's FDA-approved products
provide Vein-to-Vein(R) tracking from donor collection to patient
transfusion. Global Med is profitable, cash flow positive and has
virtually no debt.
Company:             Global Sources
Ticker Symbol & Exchange:     GSOL, NASDAQ
Investor Relations Contact:    Christiane Pelz
Investor Relations Contact Phone: 415-433-3777
Web:               http://www.globalsources.com/
Date of Presentation:       2/19/08
Global Sources (GSOL) is a leading business-to-business media company
and a primary facilitator of two-way trade with Greater China. The
core business is facilitating trade from Greater China to the world,
using a range of English-language media. The other key business
segment facilitates trade from the world to Greater China using
Chinese-language media.
The company provides sourcing information to volume buyers and
integrated marketing services to suppliers. With online marketplaces,
trade publications, and trade shows, Global Sources offers the most
extensive range of media and export marketing services in the
industries it serves.
Company:             HearUSA
Ticker Symbol & Exchange:     (AMEX: EAR)
Investor Relations Contact:    Liolios Group, Inc.
Investor Relations Contact Phone: 949-574-3860
Web:               www.hearusa.com
Date of Presentation:       Wednesday, February 20, 3:00 PM PT
HearUSA, Inc. provides hearing care to patients primarily through more
than 190 company-owned hearing care centers, which offer a complete
range of quality hearing aids with an emphasis on the latest digital
technology. HearUSA Centers are located in California, Florida, New
York, New Jersey, Massachusetts, Ohio, Michigan, Missouri, North
Carolina, and the province of Ontario, Canada. The company also
derives revenues from its HearUSA Hearing Care Network, comprised of
1,600 affiliated audiologists in 49 states, as well as its website
that enables online purchases of hearing related products, such as
batteries, hearing aid accessories and assistive listening devices.
Company:             Huiheng Medical, Inc.
Ticker Symbol & Exchange:     HHGM, OTCBB
Investor Relations Contact:    HC International, Inc.
Investor Relations Contact Phone: 760-755-2716
Web:               www.huihengmedical.com
Date of Presentation:       2/20/08
Founded in 2001 by CEO Mr. Hui Xiaobing, a pioneer in the radiation
oncology market in China, Huiheng Medical is a leading developer,
manufacturer (OEM), distributor and service provider of external
radiation oncology systems in the PRC. Huiheng Medical's patented
line of gamma treatment systems ("GTS") quickly and accurately
delivers a well-defined dose of radiation to tumors while sparing
surrounding normal tissue. Customers include health care and third
party hospital equipment providers with hospitals as the end user.
Company:             I-many, Inc.
Ticker Symbol & Exchange:     (Nasdaq:IMNY)
Investor Relations Contact:    Liolios Group
Investor Relations Contact Phone: (949) 574-3860
Web:               www.imany.com
Date of Presentation:       Tuesday February 19 at 3:00 PM PT
I-many, Inc. is a leading provider of contract management software and
services for the enterprise. With more than 280 customers across 21
industries worldwide, I-many is enabling businesses to manage the
entire contract lifecycle, from pre-contract processes and contract
management to active compliance and contract optimization. The result
is an end-to-end solution that provides enterprises with greater
levels of insight into contract performance, allowing companies to
improve profitability and achieve measurable return on investment.
Company:             ICSA India Limited
Ticker Symbol & Exchange:     BSE Code: 531524
Investor Relations Contact:    ICSA India
Investor Relations Contact Phone: +91-40-23115619, 23114923, 23114928
Web:               www.icsa-india.com
Date of Presentation:       February 18, 2008
ICSA is recognized as one of the fastest growing companies in India.
- The company's revenue grew by 149% and Net margins grew by 151% over
the last 3 years (2004 to 2007). ICSA's had an EBITDA margin of 24.4%
and net margin was 17.7% in the year 2007.
- ICSA is a listed company on Indian stock exchanges (BSE Sensex,
NSE).
- The company develops and deploys IT solutions for Power, Oil & Gas,
and water sectors and provides infrastructure deployment services for
power generation, transmission distribution and rural
electrification.
- ICSA caters to government and the private players in India. ICSA has
also started operations in Singapore and entered into JV's and
partnerships to expand into Asia and the Middle East.
- ICSA is participating in a niche segment with relatively little
competition.
Company:             InPlay Technologies, Inc.
Ticker Symbol & Exchange:     NPLA - NASDAQ
Investor Relations Contact:    Heather Beshears
Investor Relations Contact Phone: 480-586-3357
Web:               www.inplaytechnologies.com
Date of Presentation:       2/21/08
InPlay Technologies is a developer of innovative human interface
devices for electronic products. The company's FinePoint division
offers the only digital-based pen-input solution for the rapidly
growing mobile computing market. With InPlay's digital technology,
OEMs have an almost limitless roadmap for development of new features
and functions for product designs. The Company's Duraswitch(R) brand
of electronic switch technologies couples the friendly tactile
feedback of mechanical pushbuttons and rotary dials with the highly
reliable, thin profile of membrane switches enabling OEMs to create
ergonomic, space saving input panels for a wide range of
applications.
Company:             Ivivi Technologies, Inc.
Ticker Symbol & Exchange:     NASDAQ: IVVI
Investor Relations Contact:    Alison Ziegler
Investor Relations Contact Phone: 212-554-5469
Web:               www.ivivitechnologies.com
Date of Presentation:       2/19/08
Based in Montvale, NJ, Ivivi Technologies, Inc. is a medical
technology company focusing on designing, developing and
commercializing its proprietary electrotherapeutic technology
platform. Ivivi's research and development activities are focused
specifically on pulsed electromagnetic field, or PEMF, technology,
which, by creating a therapeutic electrical current in injured soft
tissue, modulates biochemical and physiological healing processes to
help repair the injured tissue and reduce related pain and
inflammation. The Company's Electroceuticals(TM) have been used in
non-invasive treatments for a wide array of conditions, including
chronic wounds, pain and edema following plastic and reconstructive
surgery and chronic inflammatory disorders.
Company:             Javo Beverage Company
Ticker Symbol & Exchange:     JAVO:OTC
Investor Relations Contact:    Marlon Nurse
Investor Relations Contact Phone: Porter, LeVay & Rose, Inc. (212)
                 564-4700
Web:               www.javobeverage.com
Date of Presentation:       2/19/08
Javo(R) Beverage Company is an innovator and leader in the manufacture
of coffee and tea-based dispensed beverages, drink mixes and flavor
systems. The Company has successfully commercialized a proprietary
brewing technology that yields fresh brewed coffees and teas that are
flavorful, concentrated and stable. As a result, they have broad
applications in the food service, food manufacturing and beverage
industries.
For food service operators, Javo makes it possible to serve great
tasting hot coffees and cold specialty coffee beverages from
convenient dispenser-based systems. Javo also assists food and
beverage processors seeking authentic and robust coffee and tea
flavors with the development and supply of customized ingredients for
their packaged foods and ready-to-drink beverages.
Company:             Jingwei International
Ticker Symbol & Exchange:     OTC BB: JNGW
Investor Relations Contact:    Ashley Ammon MacFarlane
Investor Relations Contact Phone: 203-682-8200
Web:               http://www.jingweicom.com/index.html
Date of Presentation:       2/19/08
Jingwei International ("Jingwei") is a data mining and marketing
services provider in China. With a database of over 300 million
Chinese consumers, Jingwei's services include market segmentation,
customer trend and churn analysis, and direct marketing such as
telemarketing. The Company also operates a software services
business, providing a broad range of billing and software systems for
China's mobile telecommunication carriers. Jingwei plans to evolve
into a robust marketing services provider by adding digital media
services to its current suit of offerings. These include mobile phone
advertising and outdoor LED panel advertising which engage the
consumer more effectively than advertising via traditional media.
Company:             Kintera
Ticker Symbol & Exchange:     KNTA
Investor Relations Contact:    Tara Plappert
Investor Relations Contact Phone: 858.795.3199
Web:               www.kintera.com
Date of Presentation:       Feb. 20, 2008
Kintera(R), Inc. (NASDAQ: KNTA) provides software as a service to help
organizations quickly and easily reach more people, raise more money
and run more efficiently. The Kintera Sphere(R) technology platform
empowers The Giving Experience(TM), and features a social constituent
relationship management (CRM) system, enabling donor management, e-
mail and communications, Web sites, events, advocacy programs, wealth
screening and accounting. In addition, the Kintera Connect(TM) open
platform enables clients and partners to integrate directly with
Kintera technology, resulting in the availability of best of breed
solutions through the Kintera Connect partner program.
For more information about Kintera software and services, visit
www.kintera.com
Company:             Knot Inc., The
Ticker Symbol & Exchange:     KNOT Nasdaq
Investor Relations Contact:    Sylvia Dresner
Investor Relations Contact Phone: 212-616-6161
Web:               www.theknot.com
Date of Presentation:       2/19/08
A leading lifestage media company, The Knot's flagship brand is the
nation's leading wedding resource, reaching well over a million
engaged couples each year through the #1 wedding website TheKnot.com.
Related products include The Knot national and local magazines, The
Knot books and television programming aired on the Style and Comcast
Networks. The Knot's WeddingChannel.com is the most visited wedding
gift registry website. The Nest brand focuses on newlyweds-to-
pregnancy with TheNest.com, home decor books with Clarkson Potter,
The Nest magazine and baby offshoot TheNestBaby.com. Other sites
include WeddingTracker.com; GiftRegistryLocator.com, PartySpot.com;
PromSpot.com; and local baby services and community site
Lilaguide.com.
Company:             Lakes Entertainment, Inc.
Ticker Symbol & Exchange:     LACO - Nasdaq
Investor Relations Contact:    Tim Cope
Investor Relations Contact Phone: Tim Cope
Web:               www.lakesentertainment.com
Date of Presentation:       2/19/08
Lakes Entertainment, Inc. currently has development and management
agreements with four separate Tribes for casino operations in
Michigan, California, and Oklahoma, for a total of five separate
casino sites. In addition, Lakes has announced plans to develop a
company owned casino resort project in Vicksburg, Mississippi. The
company also owns approximately 61 percent of WPT Enterprises, Inc.
(NASDAQ: WPTE), a separate publicly held media and entertainment
company principally engaged in the development, production and
marketing of gaming themed televised programming including the World
Poker Tour(R) television series, the operation of an online gaming
website, the licensing and sale of branded consumer products and the
sale of corporate sponsorships.
Company:             LanOptics Ltd.
Ticker Symbol & Exchange:     NASDAQ: EZCH
Investor Relations Contact:    CCGK Investor Relations
Investor Relations Contact Phone: 1-866-704-6710 / 1-646-213-1914
Web:               www.ezchip.com
Date of Presentation:       February 20, 2008 3:30pm
LanOptics is a public company traded on NASDAQ Global Market and the
Tel Aviv Stock Exchange under the symbol EZCH (formerly LNOP).
LanOptics is focused entirely on its subsidiary, EZchip Technologies.
EZchip Technologies is a fabless semiconductor company that provides
Ethernet network processors. EZchip's network processors provide the
flexibility and integration that enable triple-play data, voice and
video services in systems that make up the new Carrier Ethernet
networks. Flexibility and integration make EZchip's solutions ideal
for building systems for a wide range of applications in telecom
networks, data centers and enterprise backbones.
Company:             Lpath Inc.
Ticker Symbol & Exchange:     (OTC:LPTN)
Investor Relations Contact:    Liolios Group
Investor Relations Contact Phone: (949) 574-3860
Web:               www.lpath.com
Date of Presentation:       Tuesday February 19 at 12:00 PM PT
Lpath, Inc. is the category leader in lipidomics-based therapeutics,
an emerging field of medical science whereby bioactive signaling
lipids are targeted for treating important human diseases. ASONEP(TM)
is an antibody against LPA that holds promise for the treatment of
cancer and other diseases. A second product candidate, iSONEP(TM),
has demonstrated superior results in various preclinical AMD and
retinopathy models. Lpath's third candidate, Lpathomab(TM), is an
antibody against LPA, a key bioactive lipid that has been long
recognized as a valid disease target. The company's unique ability to
generate novel antibodies against bioactive lipids is based on its
ImmuneY2(TM) drug-discovery engine.
Company:             Maxwell Technologies, Inc.
Ticker Symbol & Exchange:     Nasdaq: MXWL
Investor Relations Contact:    Mike Sund
Investor Relations Contact Phone: (858) 503-3233
Web:               www.maxwell.com
Date of Presentation:       2/20/08
Maxwell is a leading developer and manufacturer of innovative, cost-
effective energy storage and power delivery solutions. Our
BOOSTCAP(R) ultracapacitor cells and multi-cell modules provide safe
and reliable power solutions for applications in consumer and
industrial electronics, automotive, transportation and
telecommunications. Our CONDIS(R) high-voltage grading and coupling
capacitors help to ensure the safety and reliability of electric
utility infrastructure and other applications involving transport,
distribution and measurement of high-voltage electrical energy. Our
radiation-mitigated microelectronic products include power modules,
memory modules and single board computers that incorporate powerful
commercial silicon for superior performance and high reliability in
aerospace applications.
Company:             Maxygen
Ticker Symbol & Exchange:     MAXY
Investor Relations Contact:    Michele Boudreau
Investor Relations Contact Phone: 650-298-5853
Web:               www.maxygen.com
Date of Presentation:       Tuesday, February 19
Maxygen is a biopharmaceutical company focused on developing improved
versions of protein drugs. The company's lead program, MAXY-G34, is
designed to be an improved version of PEG-GCSF for the treatment of
neutropenia. MAXY-G34 is currently in Phase II clinical trials. Also
in Maxygen's pipeline is a new Factor VIIa product candidate for the
treatment of hemophilia and new CTLA4-Ig product candidates for the
treatment of rheumatoid arthritis. Maxygen uses its proprietary DNA
shuffling technology and extensive protein modification expertise to
pursue the creation of biosuperior proteins.
Company:             Medical Action Industries Inc.
Ticker Symbol & Exchange:     Nasdaq/MDCI
Investor Relations Contact:    Richard G. Satin
Investor Relations Contact Phone: 631-231-4600
Web:               www.medical-action.com
Date of Presentation:       2/19/08
Medical Action Industries develops, manufactures, markets and supplies
a variety of disposable medical products. The Company's products are
marketed to acute care facilities in domestic and certain
international markets as well as physician, dental and veterinary
offices, out-patient surgery centers, long-term care facilities and
laboratories. Medical Action is a leading manufacturer and supplier
of patient bedside utensils, containment of medical waste, minor
procedure kits and trays, sterile disposable operating room towels
and sterile disposable laparotomy sponges. The Company's products are
marketed by its direct sales personnel and extensive network of
distributors. The Company's common stock trades on the NASDAQ Global
Select Market under the symbol MDCI and is included in the Russell
2000 Index.
Company:             NAPCO Security Systems, Inc.
Ticker Symbol & Exchange:     Nasdaq: NSSC
Investor Relations Contact:    Donald Weinberger
Investor Relations Contact Phone: 212-370-4500
Web:               http://www.napcosecurity.com
Date of Presentation:       2/19/08
NAPCO Security Systems, Inc. is one of the world's leading
manufacturers of technologically advanced -electronic security
equipment including intrusion and fire alarm systems, access control
systems and electronic locking devices. The Company's products,
including those of Alarm Lock and Continental Instruments, feature
some of the most popular and best-selling control panels, sensors,
locking devices and access control products. They are used in
residential, commercial, institutional, industrial and governmental
applications. NAPCO security products have earned a reputation for
technical excellence, reliability and innovation, poising the Company
for revenue growth in the rapidly expanding electronic security
market, a market whose current size exceeds $30 billion.
Company:             Neurologix, Inc.
Ticker Symbol & Exchange:     NRGX.OB
Investor Relations Contact:    John E. Mordock, Pres. & CEO
Investor Relations Contact Phone: 201 592 6451
Web:               www.neurologix.net
Date of Presentation:       2/21/08
Neurologix is dedicated to the discovery, development and
commercialization of life-altering gene transfer therapies for under-
served disorders of the brain and CNS, including Parkinson's disease,
epilepsy and Huntington's chorea. Neurologix's therapeutic approach
is built upon the groundbreaking research of its scientific founders
and advisors, whose accomplishments have formed the foundation of
gene therapy for neurological illnesses.
Company:             NexMed, Inc.
Ticker Symbol & Exchange:     NEXM: Nasdaq
Investor Relations Contact:    Paula Schwartz
Investor Relations Contact Phone: 917-322-2216
Web:               http://www.nexmed.com
Date of Presentation:       2/20/08
NexMed, Inc. is leveraging its proprietary NexACT drug delivery
technology to develop innovative topical pharmaceutical products that
address unmet medical needs. NexMed's novel onychomycosis treatment,
licensed to Novartis, is currently in pivotal Phase 3 trials in the
U.S. and Europe. The Company's topical treatment for erectile
dysfunction is licensed to Warner Chilcott, Ltd., and its New Drug
Application was accepted for review by the FDA in November 2007.
NexMed's pipeline also includes a Phase 2 treatment for female sexual
arousal disorder and an early stage treatment for psoriasis.
Company:             On Track Innovations, Ltd
Ticker Symbol & Exchange:     NASDAQ GM: OTIV
Investor Relations Contact:    Galit Mendelson
Investor Relations Contact Phone: 201 944-5200
Web:               www.otiglobal.com
Date of Presentation:       2/20/08
Established in 1990, OTI designs, develops and markets secure
contactless microprocessor-based smart card technology to address the
needs of a wide variety of markets. Applications developed by OTI
include product solutions for petroleum payment systems, homeland
security solutions, electronic passports and IDs, payments, mass
transit ticketing, parking, loyalty programs and secure campuses. OTI
has a global network of regional offices to market and support its
products. The company was awarded the Frost & Sullivan 2005 and 2006
Company of the Year Award in the field of smart cards.
Company:             Organic To Go Food Corporation
Ticker Symbol & Exchange:     (OTCBB: OTGO)
Investor Relations Contact:    Terri MacInnis
Investor Relations Contact Phone: 818.379.8500
Web:               www.organictogo.com
Date of Presentation:       2/20/08
Organic To Go's delicious organic food is now available in over 160
locations - including 26 cafes, over 120 wholesale locations, 14
universities and 9 locations at Los Angeles International Airport.
The Company started the year with 12 cafes and closed a year of
growth and expansion with 26 cafes, and it now operates Cafe's,
Catering and a growing Wholesale Grab and Go business in three
geographic regions.
Company:             Pet DRx Corporation
Ticker Symbol & Exchange:     PDXC / OTCBB
Investor Relations Contact:    Kathy Price
Investor Relations Contact Phone: 213-486-6547
Web:               www.petdrx.com
Date of Presentation:       February 20, 2008 at 8:30am PT
Pet DRx Corporation provides veterinary primary care and specialized
services to companion animals through a network of fully-owned
veterinary hospitals. The Company currently owns and operates 26
leading veterinary hospitals in the state of California, which it has
organized into unique, regional "hub and spoke" networks. Pet DRx
provides a full range of medical treatments, including preventive
care measures such as examinations, vaccinations, spaying/neutering
and dental care, as well as specialized services such as internal
medicine, surgery, cardiology, ophthalmology, dermatology, oncology,
neurology, x-ray and ultrasound.
Company:             Phoenix Technologies, Ltd.
Ticker Symbol & Exchange:     NASDAQ: PTEC
Investor Relations Contact:    Sapphire Investor Relations, L
Investor Relations Contact Phone: 212-766-1800
Web:               www.phoenix.com
Date of Presentation:       2/19/08
Phoenix Technologies Ltd. is the global market leader in system
firmware that provides the most secure foundation for today's
computing environments. The PC industry's top builders and specifiers
trust Phoenix to pioneer open standards and deliver innovative
solutions that will help them differentiate their systems, reduce
time-to-market and increase their revenues. Flagship products include
AwardCore, SecureCore, FailSafe and HyperSpace, are revolutionizing
the PC user experience by delivering unprecedented security,
reliability and ease-of-use. The Company established industry
leadership with its original BIOS product in 1983, has 155 technology
patents and 139 pending applications, and has shipped in over one
billion systems.
Company:             Pluristem Therapeutics Inc.
Ticker Symbol & Exchange:     NASDAQ:PSTI ;DAX:PJT
Investor Relations Contact:    CEOcast - Mr. Michael Wachs
Investor Relations Contact Phone: +1-212-732-4300 x225
Web:               www.pluristem.com
Date of Presentation:       19 February 2008 at 1:00 pm
Pluristem Therapeutics, Inc. is a bio-therapeutics company, dedicated
to the commercialization of non-personalized (allogeneic) cell
therapy products, targeting a variety of degenerative, malignant and
autoimmune disorders.
Pluristem is striving to give patients an improved quality of life
through the miracle of birth.
The Company is expanding non-controversial placental-derived
mesenchymal stromal cells (MSCs) via a proprietary 3D expansion
technology, termed PluriX(TM). The expanded cells are termed PLX
(PLacenta eXpanded cells).
The market potential of all Pluristem's therapeutic products is an
estimated annual $30B, targeting Bone Marrow Transplant (BMT),
Peripheral Artery Disease (PAD), Ischemic Stroke and a variety of
autoimmune disorders.
Company:             Precious Sheen Investments Ltd.,
                 CHUMING
Ticker Symbol & Exchange:     ENHD, OTCBB
Investor Relations Contact:    HC International, Inc.
Investor Relations Contact Phone: (858) 704-5065
Web:               www.chuminggroup.com
Date of Presentation:       2/21/08
Chuming is a leading regional producer and distributor of fresh and
prepared meat products in Northeastern China. The Company focuses on
pork, the PRC's most consumed and produced meat and specializes in
processing and distribution of Chuming-branded products. Chuming is a
contract supplier of premium pork products to more than 3,600 retail
locations, including Wal-Mart, Metro, Carrefour, New-Mart, Hymall and
supply its own network of 500+ Chuming-branded franchise stores.
Chuming's processing and distribution facilities maintain ISO 9001
and HACCP certifications. Chuming is the first company in China's
meat industry to receive the coveted "Green Food" Certification from
the Ministry of Agriculture. For the first nine months of 2007, its
sales increased 78.7% to $89.7 million with net income increasing 31%
to $8.3 million.
Company:             Response Genetics
Ticker Symbol & Exchange:     RGDX (NASDAQ)
Investor Relations Contact:    Peter Rahmer - The Trout Group
Investor Relations Contact Phone: 646-378-2925
Web:               www.responsegenetics.com
Date of Presentation:       2/20/08
Response Genetics, Inc. ("RGI") (NASDAQ: RGDX) is engaged in the
research and development of pharmacogenomic cancer diagnostic tests
based on its proprietary and patented technologies. RGI's
technologies enable extraction and analysis of genetic information
from genes derived from tumor samples stored as formalin-fixed and
paraffin embedded specimens. RGI currently generates revenue
primarily from the sales of its proprietary analytical
pharmacogenomic testing services of clinical trial specimens to the
pharmaceutical industry. The company was founded in 1999 and its
principal headquarters are located in Los Angeles, California.
Company:             Silverstar Holdings, Ltd.
Ticker Symbol & Exchange:     (Nasdaq:SSTR)
Investor Relations Contact:    Liolios Group
Investor Relations Contact Phone: (949) 574-3860
Web:               http://www.silverstarholdings.com/
Date of Presentation:       Tuesday, February 19 at 2:00 PM PT
Silverstar Holdings, Ltd. is an international publisher and developer
of interactive entertainment software. It currently owns Empire
Interactive, PLC and Strategy First, Inc. Empire Interactive
(http://www.empireinteractive.com) is a leading developer and
publisher of interactive entertainment software games, including
Starsky & Hutch, Big Mutha Truckers, Ford Racing and FlatOut.
Empire's products are delivered on both console and PC platforms.
Strategy First (http://www.strategyfirst.com) is a developer and
worldwide publisher of entertainment software for the PC. For more
information about Silverstar Holdings visit
http://www.silverstarholdings.com
Company:             Sino Gas International Holdings,
                 Inc.
Ticker Symbol & Exchange:     SGAS: OTC BB
Investor Relations Contact:    Crocker Coulson
Investor Relations Contact Phone: 646 213-1915
Web:               http://www.sino-gas.com
Date of Presentation:       2/19/08
Sino Gas is a leading developer of natural gas distribution systems in
small and medium size cities, as well as a distributor of natural gas
to residential, commercial and industrial customers in China.
Revenues come from acquiring and developing distribution systems,
expanding natural gas sales, connecting customers to natural gas
lines, and appliance and equipment sales. The company owns and
operates 24 natural gas distribution systems, serving approximately
70,000 residential customers as of the end of September 2007.
Revenues (9 months 2007) were $10.88 million, up 119.0% over the same
period a year earlier, and market capitalization at a price of $3.20
a share is $96.3 million.
Company:             Smart Online, Inc.
Ticker Symbol & Exchange:     SOLN / OTCBB
Investor Relations Contact:    Thomas Furr
Investor Relations Contact Phone: 919-237-4189
Web:               www.smartonline.com
Date of Presentation:       February 21, 2008 at 11:30 am
Smart Online is the nation's premier provider of private label
applications for micro businesses. Our software-as-a-service (SaaS)
applications enable corporations to attract and retain micro
businesses customers in a new way. We assist our corporate partners
by integrating branding, marketing, and usability. As a result, they
gain more customers and receive higher revenues per customer. We
listen, we deliver.
Company:             Solar Power, Inc.
Ticker Symbol & Exchange:     SOPW, OTCBB
Investor Relations Contact:    HC International, Inc.
Investor Relations Contact Phone: 760-755-2716
Web:               www.solarpowerinc.net
Date of Presentation:       2/20/08
Founded in 2005, Solar Power Inc. (SPI) is a vertically integrated
solar energy solution provider offering the North American
residential, commercial and public sector building markets a complete
solution through a single brand. With a state of the art
manufacturing facility in Shenzhen, China, Solar Power Inc. provides
turnkey design-build solutions through its Sacramento, California
headquarters and a growing commercial and retail distribution network
under the SPI and Yes! Solar Solutions(TM) brand names.
Company:             Sona Mobile Holdings Corp.
Ticker Symbol & Exchange:     OTC BB: SNMB
Investor Relations Contact:    KCSA
Investor Relations Contact Phone: Tod Fromer 212-896-1215
Web:               www.sonamobile.com
Date of Presentation:       Tuesday, February 19, 2008 / 3:00pm
Sona is a leading provider of secure software solutions for gaming and
entertainment applications. Sona's patent-pending technology delivers
a rich client experience without compromising performance or
security. Sona's key differentiator is the innovative Sona Gaming
Platform (SGP). Sona utilizes the SGP to provide clients with wired
or wireless server-based gaming content including slots, table games,
video poker and race and sports wagering - all from a single screen.
The Gaming Labs International (GLI) certified SGP architecture works
across a wide range of mobile devices, kiosks, and computers. The SGP
enables clients to have a similar gaming interface in a casino, at
the track, at home on their computer or on their mobile device.
Company:             Symmetricom
Ticker Symbol & Exchange:     SYMM
Investor Relations Contact:    Bill Slater
Investor Relations Contact Phone: 408-428-7801
Web:               www.symmetricom.com
Date of Presentation:       2/19/08
Symmetricom is a world leader in the generation and synchronization of
precise time and frequency signals. The company designs, manufactures
and markets atomic clocks and network synchronization and timing
solutions used in wireline and wireless telecom networks, space,
defense and avionics systems, and enterprise IT networks. Our
customers include network service providers, telecom equipment
manufacturers, military and aerospace contractors, enterprises, as
well as government and research facilities in over 90 countries
around the globe. Symmetricom's QoE Assurance Division provides end-
to-end network performance monitoring and diagnostic products for
carriers, service providers and enterprises that seek to deliver
revenue-critical triple play services.
Company:             Telanetix
Ticker Symbol & Exchange:     TNXI, OB
Investor Relations Contact:    Moriah Shilton
Investor Relations Contact Phone: 415-433-3777
Web:               www.telanetix.com/
Date of Presentation:       2/21/08
Telanetix is a leading internet protocol (IP) solutions provider
offering telepresence and voice over IP (VoIP) services to the small-
to-medium businesses and enterprise (SMB and SME) markets. By
leveraging on ubiquitous network infrastructures, Telanetix's
solutions meet the real-world communications demands of its
customers. The company's telepresence offering, called Digital
Presence(TM), creates fully immersive and interactive meeting
environments that incorporate voice, video and data from multiple
locations into a single environment at better quality and much lower
price than competitors. The AccessLine Division provides VoIP
services and gives companies flexible calling solutions at a fraction
of the price of traditional telecom providers.
Company:             TeleCommunication Systems Inc.
Ticker Symbol & Exchange:     (Nasdaq:TSYS)
Investor Relations Contact:    Liolios Group
Investor Relations Contact Phone: (949) 574-3860
Web:               www.telecomsys.com
Date of Presentation:       Tuesday February 19 at 4:00 PM PT
TeleCommunication Systems, Inc. produces wireless data communications
technology solutions that require proven high levels of reliability.
TCS provides wireless and VoIP E9-1-1 network-based services, secure
deployable communication systems and engineered satellite-based
services, and commercial location applications, like traffic and
navigation, using the precise location of a wireless device.
Customers include leading wireless, cable and VoIP carriers around
the world and agencies of the U.S. Departments of Defense, State, and
Homeland Security.
Company:             Think Partnership, dba, Kowabunga!
Ticker Symbol & Exchange:     THK AMEX
Investor Relations Contact:    Ina McGuinness, Sr VP ICR, Inc.
Investor Relations Contact Phone: 310-954-1100
Web:               www.kowabunga.com
Date of Presentation:       2/21/08
Think Partnership is doing business under the name, "Kowabunga!"
Kowabunga! is an international leader in creating proprietary
technologies that drive interactive, performance-based marketing.
We acquired our first online marketing company in 2004. Since then, we
have added 8 more online marketing companies, an online education
company, and a series of online community companies.
Today, Kowabunga! offers a variety of online and offline marketing
solutions for businesses. The independent solutions have been
integrated with one another to offer comprehensive packages to assist
advertisers in marketing their websites and offer affiliates and
publishers the opportunity to monetize their traffic and subscriber
base.
Company:             Trinity Biotech
Ticker Symbol & Exchange:     TRIB
Investor Relations Contact:    Ms. Niamh Long
Investor Relations Contact Phone: + 353 1 274 3266
Web:               www.trinitybiotech.com
Date of Presentation:       Tuesday 19th February
Trinity Biotech develops, acquires, manufactures and markets
diagnostic systems, including both reagents and instrumentation, for
the point-of-care and clinical laboratory segments of the diagnostic
market. The products are used to detect infectious diseases and blood
coagulation disorders, and to quantify the level of Haemoglobin A1c
and other chemistry parameters in serum, plasma and whole blood.
Trinity Biotech sells direct in the United States, Germany, France
and the U.K. and through a network of international distributors and
strategic partners in over 75 countries worldwide. For further
information please see the Company's website: www.trinitybiotech.com.
Company:             UCN Inc.
Ticker Symbol & Exchange:     (Nasdaq:UCNN)
Investor Relations Contact:    Liolios Group
Investor Relations Contact Phone: (949) 574-3860
Web:               www.ucn.net
Date of Presentation:       Wed, February 20 at 12:00 PM PT
UCN is the leading provider of all-in-one, off-premises contact
handling services that improve the customer contact experience and
the productivity of those handling the contacts. InContact(R)
includes an integrated suite of contact handling applications,
including contact routing, interactive menus, database integration,
automated surveys and scoring analysis, reporting, monitoring,
recording, administration and workforce scheduling and forecasting
applications. InControl(TM) is a unique, rapid application
development tool that enables inContact customers to develop highly
flexible, customized business contact handling processes in record
time.
Company:             Vertical Branding, Inc.
Ticker Symbol & Exchange:     VBDG (OTC BB)
Investor Relations Contact:    Sean Collins, Sr. Partner, CCG
Investor Relations Contact Phone: 310-497-9205
Web:               www.verticalbranding.com
Date of Presentation:       Feb. 20, 2008
Vertical Branding is a consumer products company selling high-quality
household, beauty and personal care products at affordable prices.
The Company builds consumer awareness for its products and brands
through direct response television, Internet and print advertising,
supporting broad distribution to many of the country's largest
retailers and drug chains as well as catalogs, home shopping channels
and international distributors. Vertical Branding develops its own
proprietary products and brands and licenses the rights to other
select products that pass its rigorous screening process. The
Company's hottest-selling products and brands currently include
Hercules Hook, ZorbEEZ, EZ Foldz Step Stool and StarMaker Cosmetics.
Company:             WaferGen Biosystems, Inc.
Ticker Symbol & Exchange:     OTCBB: WGBS
Investor Relations Contact:    Stephanie Diaz
Investor Relations Contact Phone: (415) 675-7401
Web:               www.wafergen.com
Date of Presentation:       Wednesday, February 20th at 5:00pm
WaferGen Biosystems Inc. is a leader in the development, manufacture
and sale of state-of-the-art systems for gene expression, genotyping,
cell biology and stem cell research for the life science and
pharmaceutical industries. The company is actively developing its
SmartChip product for the gene expression and genotyping markets.
SmartChip is being developed as the first whole genome, high
throughput gene expression real-time polymerase chain reaction (PCR)
platform and promises to deliver significant speed and cost
advantages to researchers in the gene expression and genotyping
markets. Launched in 2006, WaferGen's SmartSlide family of products
represent the first fluidics integrated micro-incubators enabling
cell biology and stem cell research.
Company:             Zila, Inc.
Ticker Symbol & Exchange:     Nasdaq: ZILA
Investor Relations Contact:    Robert Jaffe
Investor Relations Contact Phone: 310-279-5969
Web:               www.zila.com
Date of Presentation:       2/19/08
Zila, Inc., is a fully integrated oral diagnostic company dedicated to
the prevention, detection and treatment of oral cancer and
periodontal disease. ViziLite(R) Plus, the company's flagship product
for the early detection of oral abnormalities that could lead to
cancer, is the first and only adjunctive medical device cleared by
the FDA for use in a population at increased risk for oral cancer.
Zila also designs, manufactures and markets a suite of proprietary
products sold exclusively to dental professionals for periodontal
disease, including the Rota-dent(R) Professional Powered Brush, the
Pro-Select(R) Platinum ultrasonic scaler and a portfolio of oral
pharmaceutical products.

[ Back To TMCnet.com's Homepage ]